You guys are taking safe harbor statements out of context. Rules and guidance for a 10K demands that every possibility be mentioned. One possibility is a delay of FluCide. But, that only happens if EbolaCide 2 works phenomenally and the company is suddenly showered with money from government sources. Otherwise, the BASi tox studies move forward without hindrance from ebola testing and progress.
Moreover, all the pointing to statements about the reasons for slow progress in scaling up, that has to remain in the 10K until scale up is complete AND the GMP facility is fully functional and producing cGMP material at scale. Seymour has repeatedly said that they already have the equipment.